Immunogenic and tolerogenic signatures in human immunodeficiency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control

Clinical and Experimental Immunology

Volumn 166, Issue 2, 2011, Pages 208-217

  Whittall, T ^a   Peters, B ^a   Rahman, D ^a   Kingsley, C I ^a   Vaughan, R ^a   Lehner, T ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cellular factors cytokines; HIV; Immune reconstitution; Virus cell interaction

Indexed keywords

CD40 LIGAND; CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 4; INTERLEUKIN 6; KI 67 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROGRAMMED DEATH 1 RECEPTOR; T LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; BIOMASS CONVERSION; CD4+ CD25+ T LYMPHOCYTE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CONTROL; DISEASE COURSE; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; UPREGULATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD274; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD40 LIGAND; CHEMOKINE CCL3; CHEMOKINE CCL4; CTLA-4 ANTIGEN; DISEASE PROGRESSION; FLOW CYTOMETRY; HISTOCOMPATIBILITY TESTING; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-4; INTERLEUKIN-6; KI-67 ANTIGEN; LECTINS, C-TYPE; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR5; T-LYMPHOCYTES, REGULATORY;

EID: 80053652092     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04463.x     Document Type: Article

References (49)

1. Kornfeld C, Ploquin MJ, Pandrea I etal. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 2005; 115:1082-91.
2. Sharp PM, Shaw GM, Hahn BH. Immunodeficiency virus infection of chimpanzee. J Virol 2005; 79:3891-902.
3. Madec Y, Boufassa F, Porter K, Meyer L. Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters. AIDS 2005; 19:2001-7.
4. Lambotte O, Boufassa F, Madec Y, Venet A, Delfraissy JF. HIV controllers: a homogeneous group of HIV-1 infected patients with spontaneous control of viral replication. Clin Invest Dis 2005; 41:1053-6.
5. Cao Y, Qin L, Zhang L, Safrit J, Ho DD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995; 332:201-8.
6. + lymphocytes. J Acquir Immune Defic Syndr 1995; 8:496-505.
7. Goudsmit J, Bogaards JA, Jurriaans S etal. Naturally HIV-1 sero-converters with lowest viral load have best prognosis, but in time lose control of viraemia. AIDS 2002; 16:791-3.
8. Migueles SA, Sabbaghian MS, Shupert WL etal. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000; 97:2709-14.
9. Bailey JR, Williams TM, Siliciano RF, Blankson JN. Maintenance of viral suppression in HIV-1 infected HLA-B*57+ elite suppressors despite CTL escape mutations. J Exp Med 2006; 203:1357-69.
10. Goulder PJ, Watkins DI. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2008; 8:619-30.
11. Dean M, Carrington M, Winkler C etal. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CCR5 structural gene. Science 1996; 273:1856-62.
12. Paxton WA, Martin SR, Tse D etal. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nat Med 1996; 2:412-17.
13. Migueles SA, Laborico AC, Shupert WL etal. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002; 3:1061-8.
14. + T cells. Blood 2006; 107:4781-9.
15. Zimmerli SXC, Harari A, Cellerai C, Vallelian F, Bart PA, Pantaleo G. HIV-1 specific IFN-gamma/IL-2 secreting CD8 T cells support CD4-independent proliferation of HIV-1 specific CD8 T cells. Proc Natl Acad Sci USA 2005; 102:7239-44.
16. + T cell responses associated with control of viraemia. Science 1997; 278:1447-50.
17. Pontesilli O, Carotenuto P, Kerkhof-Garde SR etal. Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection. AIDS Res Hum Retroviruses 1999; 15:973-81.
18. + CD4 T cell responses is associated with nonprogression in HIV-1 infection. J Immunol 2002; 169:6376-85.
19. Pereyra F, Addo M, Kaufmann D etal. Genetic and immunologic heterogeneity among persons controlling HIV infection in the absence of therapy. J Infect Dis 2008; 197:563-71.
20. Kaufmann DE, Kavanagh DG, Pereyra F etal. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 2007; 8:1246-54.
21. Nilsson J, Boasso A, Veililla PA etal. HIV-1 driven regulatory T cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006; 108:3808-17.
22. + T-cell depletion in HIV disease. Nature 2001; 410:974-9.
23. + depletion in HIV infection: are we closer to understanding the cause? Nat Med 2002; 8:319-23.
24. Emu B, Sinclair E, Favre D etal. Phenotypic, functional and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol 2005; 79:14169-78.
25. Bailey JR, Lassen KG, Yang HC etal. Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy. J Virol 2006; 80:4758-70.
26. Decks SG, Schweighardt B, Wrin T etal. Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for constraint on the ability of HIV to completely evade neutralizing antibody responses. J Virol 2006; 80:6155-64.
27. Martinez V, Costagliola D, Bonduelle O etal. Combination of HIV-1 specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression. J Infect Dis 2006; 191:2053-63.
28. Audige A, Taffe P, Rickenbach M etal., Swiss HIV Cohorts Study (SHCS). Low post-seroconversion CD4 count and rapid decrease of CD4 density identify HIV+ fast progressors. AIDS Res Hum Retroviruses 2010; 26:997-1005.
29. Cao W, Jamieson BD, Hultin LE, Hultin PM, Detels R. Regulatory T cell expansion and immune activation during untreated HIV-1 type 1 infection are associated with disease progression. AIDS Res Hum Retroviruses 2009; 25:183-91.
30. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2h. Tissue Antigens 1993; 41:119-34.
31. Bunce M, O'Neill CM, Barnado CM etal. Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5, and DQB1 by PCR with 144 primer mixes utilising sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46:355-67.
32. Kristiansen TB, Krudsen TB, Ohlendorff S, Eugen-Olsen J. A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression. J Immunol Methods 2001; 252:147-51.
33. Andersson J, Boasso A, Nilsson J etal. Cutting edge: the prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 2005; 174:3143-7.
34. Nilsson J, Boasso A, Velilla PA etal. HIV-1 driven regulatory T cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006; 108:3808-17.
35. Aandahl EJ, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF. Human CD4+CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004; 78:2454-9.
36. Kinter A, McNally J, Riggin L, Jackson R, Roby G, Fauci AS. Suppression of HIV specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc Natl Acad Sci USA 2007; 104:3390-5.
37. Lim A, Tan D, Price P etal. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 2007; 21:1525-34.
38. Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, Levy Y. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004; 104:3249-56.
39. Apoil PA, Puissant F, Roubinet F, Abbal M, Massip P, Blanche A. FoxP3 mRNA levels are decreased in peripheral blood CD4+ lymphocytes from HIV-positive patients. J Acquir Immune Defic Syndr 2005; 39:381-5.
40. Kinter AL, Hennessey M, Bell A etal. CD25+CD4+ regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4+ and CD8+ HIV-specific T cell immune responses in vitro and are associated with favourable clinical markers of disease status. J Exp Med 2004; 200:331-43.
41. Chase AJ, Yang H-C, Zhang H, Blankson JN, Siliciano RF. Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation. J Virol 2008; 82:8307-15.
42. Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cells responses. Immunity 2007; 27:111-22.
43. Parry RV, Chemnitz JM, Frauwirth KA etal. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 2005; 25:9543-53.
44. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and tranduces the signal for cognate activation on B cells. Proc Natl Acad Sci USA 1992; 89:6550.
45. Quezada SS, Jarvinen LZ, Lind EF, Noelle RJ. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 2004; 22:307-28.
46. + memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming. J Exp Med 2008; 205:2561-74.
47. Wang Y, Seidl T, Whittall T, Babaahmady K, Lehner T. Stress activated dendritic cells interact with CD4+ T cells to elicit homeostatic memory. Eur J Immunol 2010; 40:1628-38.
48. Bettelli E, Carrier Y, Gao W, Kom T, Strom TB, Oukka M. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-8.
49. Kishimoto T. Interleukin-6: from basic science to medicine - 40 years in immunology. Annu Rev Immunol 2005; 23:1-21.